Church & Dwight Co Inc (CHD)
Valor JustoFundamental
67
Preço
$94.30
Capitalização de Mercado
$22.68B
Parte 1 · Quanto vale a empresa
Visão Geral
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users
P&G is the first competitor named in Church & Dwight's own 10-K and fights for the same US shelf space in laundry detergent (Tide versus Arm & Hammer and Xtra), oral care and personal care.
Clorox is the closest rival by size and profile, competing on the same US household aisle in laundry additives, cleaners and cat litter (Fresh Step versus Arm & Hammer).
Colgate-Palmolive competes head-on in oral care against Arm & Hammer toothpaste, Spinbrush and TheraBreath, and in home care and pet products sold through the same retailers.
Kenvue competes in consumer self-care, where its Listerine, Neutrogena and cold-and-allergy brands sit against TheraBreath, Hero acne treatment and Zicam.
Reckitt competes across cleaning and health-and-hygiene categories where Church & Dwight also sells, from surface cleaners to sexual wellness products rivaling Trojan.
Unilever competes in personal care and home care worldwide, with dry shampoo, deodorant and laundry brands aimed at the same shoppers as Batiste and Arm & Hammer.
Balanço & Liquidez
Receita
$6.23B
Últimos 12 meses (até 30/06/2026)
Resultado Líquido
$745M
Últimos 12 meses (até 30/06/2026)
Fluxo de Caixa Livre
$1.09B
Capital Próprio Total
$4.00B
Passivo Total
$4.91B
Rácio de Liquidez
1.15
Cobertura de Juros
11.26
Dívida/EBITDA
1.87
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$80.51
Preço Atual
$94.30
Margem de Segurança
-17.1%
Intervalo de Valor Justo
$56.29 - $104.72
Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
30.30
ROE
18.4%
Rácio P/B
5.14
P/FCF
20.75
Margem Bruta
45.6%
ROIC
11.1%
Radar de Rentabilidade
Criação de Valor (Vantagem Competitiva)
ROIC
11.1%
WACC
7.5%
ROIC − WACC
+3.5 pp
O ROIC supera o custo do capital — a empresa está a criar valor para os acionistas.
Critérios de Análise Fundamental
Aprovado (19)
- EPS shows upward trend
- Price CAGR 7.86%
- ROIC 11.0%
- Gross Margin 45.6%
- P/FCF 20.75
- Debt/Equity ratio
- Operating Margin 17.5%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 17.8%
- Analyst Consensus 50% Buy
- Earnings Quality (OCF/NI) 1.65
- Share Dilution -1.2%
- Net Margin Trend 12.0% vs 8.7%
- Piotroski F-Score 6/9
Reprovado (7)
- EPS CAGR 0.49%
- P/B Ratio 5.14
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Revenue Growth 5Y 4.8%
- Earnings Surprise avg 2.5%
Indisponível (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Sinais mistos: algumas áreas requerem atenção
Qualidade dos Resultados
Alta qualidade: resultados respaldados por caixa
Diluição de Ações
A recomprar ações. Favorável ao acionista
Participações institucionais
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Mr. Richard A. Dierker | President, CEO & Director | 45 |
| Mr. Lee B. McChesney | CFO & Executive VP | 53 |
| Mr. Patrick D. de Maynadier Esq., J.D. | Executive VP, General Counsel & Secretary | 65 |
| Mr. Michael G. Read | Executive Vice President of International | 50 |
| Mr. Charles R. Raup | Executive VP & President of US Domestic | 57 |
| Mr. Joseph James Longo | VP, Chief Accounting Officer & Corporate Controller | 54 |
| Mr. Carlos G. Linares | Executive VP, CTO & Global New Product Innovation | 61 |
| Ms. Stacey Ramstedt | Senior VP & Chief Marketing Officer | - |
| Ms. Rene M. Hemsey | Executive VP & Chief Human Resources Officer | 57 |
| Mr. Brian Buchert | Executive VP of Strategy, M&A and Business Partnerships | - |
Risco de Auditoria
4
Risco do Conselho
4
Risco de Remuneração
2
Risco dos Direitos dos Acionistas
5
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Documentos
- Ver documento
Relatório anual (10-K)
Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.
Arquivado em 2026-02-12
- Ver documento
Relatório trimestral (10-Q)
Uma atualização sobre o desempenho financeiro dos últimos três meses.
Arquivado em 2026-07-31
- Ver documento
Relatório de fato relevante (8-K)
Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.
Arquivado em 2026-07-31
via SEC EDGAR
Histórico de Resultados
via SEC EDGAR
Latest News
Recent headlines for CHD, sourced from Markets Gazette.